J-P Machiels Selected Research

Deoxyglucose (2 Deoxy D glucose)

1/2018

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J-P Machiels Research Topics

Disease

10	Squamous Cell Carcinoma of Head and Neck 12/2023 - 07/2009
10	Neoplasms (Cancer) 12/2023 - 08/2012
3	Carcinoma (Carcinomatosis) 04/2014 - 10/2012
2	Residual Neoplasm 12/2023 - 09/2013
2	Disease Progression 01/2023 - 07/2015
2	Breast Neoplasms (Breast Cancer) 11/2013 - 06/2011
2	Transitional Cell Carcinoma 09/2013 - 10/2012
2	Heart Failure 03/2008 - 03/2008
2	Rectal Neoplasms (Rectal Cancer) 04/2007 - 12/2005
1	Nasopharyngeal Carcinoma 01/2023
1	Ovarian Epithelial Carcinoma 10/2022
1	Glioblastoma (Glioblastoma Multiforme) 10/2022
1	Hepatocellular Carcinoma (Hepatoma) 10/2022
1	Multiple Myeloma 10/2022
1	Diarrhea 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Hypoxia (Hypoxemia) 11/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2013
1	Adenocarcinoma 06/2006
1	Colorectal Neoplasms (Colorectal Cancer) 12/2005
1	Neoplasm Metastasis (Metastasis) 12/2005

Drug/Important Bio-Agent (IBA)

4	Cetuximab (Erbitux)FDA Link 12/2023 - 04/2007
3	PlatinumIBA 12/2023 - 10/2012
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2012
3	Capecitabine (Xeloda)FDA Link 04/2007 - 12/2005
2	B7-H1 AntigenIBA 01/2023 - 10/2022
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 05/2013
2	AfatinibIBA 01/2018 - 05/2013
2	ErbB Receptors (EGF Receptor)IBA 07/2015 - 08/2012
2	TOR Serine-Threonine KinasesIBA 11/2013 - 10/2012
2	Sirolimus (Rapamycin)FDA Link 11/2013 - 09/2013
2	MTOR InhibitorsIBA 11/2013 - 09/2013
2	Everolimus FDA Link 09/2013 - 10/2012
2	Sunitinib (Sutent)FDA Link 03/2008 - 03/2008
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2006 - 12/2005
1	pembrolizumabIBA 12/2023
1	Circulating Tumor DNAIBA 12/2023
1	Docetaxel (Taxotere)FDA Link 12/2023
1	Methotrexate (Mexate)FDA LinkGeneric 12/2023
1	durvalumabIBA 01/2023
1	tremelimumabIBA 01/2023
1	CTLA-4 AntigenIBA 01/2023
1	atezolizumabIBA 10/2022
1	isatuximabIBA 10/2022
1	FluorineIBA 01/2018
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2018
1	Monoclonal AntibodiesIBA 07/2015
1	EpitopesIBA 07/2015
1	futuximabIBA 07/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2014
1	Chloroquine (Aralen)FDA LinkGeneric 11/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2013
1	Cisplatin (Platino)FDA LinkGeneric 05/2013
1	figitumumabIBA 08/2012
1	Insulin (Novolin)FDA Link 08/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2012
1	Vinca AlkaloidsIBA 06/2011
1	TubulinIBA 06/2011
1	vinflunineIBA 06/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2011
1	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 07/2009
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 07/2009
1	Antineoplastic Agents (Antineoplastics)IBA 12/2005

Therapy/Procedure

6	Therapeutics 12/2023 - 10/2012
4	Drug Therapy (Chemotherapy) 12/2023 - 07/2009
3	Radiotherapy 04/2007 - 12/2005
1	Combined Modality Therapy 12/2023
1	Aftercare (After-Treatment) 10/2022
1	Immunotherapy 10/2022
1	Regimen B 05/2013
1	Neoadjuvant Therapy 06/2006